Koch Ventures

Koch Disruptive Technologies (KDT), often referred to as Koch Ventures, is the venture capital arm of Koch Industries, one of the largest private companies in the United States. Founded in 2017, KDT focuses on investing in early-stage and growth-stage companies that are developing transformative technologies across various sectors, including healthcare, life sciences, and medical technology. The firm's healthcare investment strategy prioritizes disruptive innovations such as AI-driven drug discovery, synthetic biology, non-invasive medical devices, and digital health platforms. By leveraging the vast resources and global network of Koch Industries, KDT provides its portfolio companies with strategic guidance and operational support to scale their impact on global health.